Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion type Assertion NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_head.
- NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_provenance.
- NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion evidence source_evidence_literature NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_provenance.
- NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion SIO_000772 15721400 NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_provenance.
- NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion wasDerivedFrom befree-20140225 NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_provenance.
- NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_assertion wasGeneratedBy ECO_0000203 NP761646.RA9xOUg9cdUTBIrS1gv185TwrlApLMisMvGtAzxuNYcr8130_provenance.